LOGIN  |  REGISTER
Recursion

Recent Insider Transactions - Acrivon Therapeutics (NASDAQ: ACRV)

Follow NASDAQ:ACRV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACRV Acrivon Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
DiRocco Derek / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
TOMSICEK MICHAEL JOHN / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
Shacham Sharon / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
Palani Santhosh / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
Magovcevic-Liebisch Ivana / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
BAUM CHARLES M / director
06/13/2025
Buy
$1.20
20,275
$24K
20,275
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
05/21/2025
Sell
$1.15
19,904
$23K
2.21M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous